Growth hormone treatment for neurologic symptoms of post‐acute sequelae of COVID‐19

Growth hormone treatment for neurologic symptoms of post‐acute sequelae of COVID‐19

Abstract Following SARS‐CoV‐2 infection, some patients develop lingering neurologic symptoms of post‐acute sequelae of COVID‐19 (PASC) that commonly include fatigue and “brain fog.” PASC symptoms are also linked with reduced growth hormone (GH) secretion, but GH treatment has not been tested to reli...

Full description

Bibliographic Details
Main Authors: Traver J. Wright, Melinda Sheffield‐Moore, Richard B. Pyles, Kathleen M. Randolph, Kristen A. McGovern, Christopher P. Danesi, Sarah E. Lindsay, Mohammed F. Zaidan, Brent E. Masel, Randall J. Urban
Format: Article
Language:English
Published: Wiley 2024-06-01
Series:Clinical and Translational Science
Online Access:https://doi.org/10.1111/cts.13826

Internet

https://doi.org/10.1111/cts.13826

Similar Items